Sign in
4

Changes in Ownership

RedHill Biopharma Ltd. Filed Acc 0001178913-26-003473

Chief Operating Officer sold 14,130,000 shares at $0.00 ($1,413)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Raday Gilead Chief Operating Officer 2026-07-10 Sale −14,130,000 $0.00 $1,413 218,780,000 D
Derivatives
Raday Gilead Chief Operating Officer 2026-07-10 Option exercise · American Depositary Shares +28,150,000 104,130,000 D
Open-market sales · 14,130,000 sh · avg $0.00 · $1,413
Loading xslF345X06/ownership.xml…